Andy Chevigne
Esch-sur-alzette, ES, Luxembourg
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 92 publications
Atypical GPCR Activation Resolved by Nanobody Engineering.
Journal: bioRxiv : the preprint server for biology
Published: January 16, 2026
Deciphering Opioid Peptide Binding Modes at Atypical Chemokine Receptor 3.
Journal: ACS pharmacology & translational science
Published: November 03, 2025
Physical interaction with Ephrin B1 promotes CXCR4 intracellular localization and oncogenic potential.
Journal: Cellular and molecular life sciences : CMLS
Published: July 17, 2025
Regulation of the orphan G-protein-coupled receptor GPRC5B by MLC1 and the cell adhesion molecule GlialCAM in megalencephalic leukoencephalopathy.
Journal: The Journal of biological chemistry
Published: July 02, 2025
Biased antagonism of a series of bicyclic CXCR2 intracellular allosteric modulators.
Journal: Frontiers in pharmacology
Published: May 19, 2025
Retinal determination network reactivation drives chemoresistance and blocks myeloid differentiation in acute myeloid leukemia.
Journal: Cell reports
Published: March 03, 2025
GPR15LG binds CXCR4 and synergistically modulates CXCL12-induced cell signaling and migration.
Journal: Cell communication and signaling : CCS
Published: February 11, 2025
Inclusion of ACKR5 in the systematic nomenclature of atypical chemokine receptors.
Journal: Nature reviews. Immunology
Published: February 03, 2025
Extended repertoire of CXC chemokines acting as agonists and antagonists of the human and murine atypical chemokine receptor ACKR2.
Journal: Journal of leukocyte biology
Published: September 04, 2024
Novel Small-Molecule Atypical Chemokine Receptor 3 Agonists: Design, Synthesis, and Pharmacological Evaluation for Antiplatelet Therapy.
Journal: Journal of medicinal chemistry
Published: August 08, 2024
Last Updated: 09/26/2026